Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |